VANI vs. ZYXI, AXGN, EDAP, OM, SMLR, ELMD, FONR, HYPR, MOVE, and CUTR
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Zynex (ZYXI), AxoGen (AXGN), Edap Tms (EDAP), Outset Medical (OM), Semler Scientific (SMLR), Electromed (ELMD), FONAR (FONR), Hyperfine (HYPR), Movano (MOVE), and Cutera (CUTR). These companies are all part of the "electromedical equipment" industry.
Vivani Medical (NASDAQ:VANI) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.
Zynex has a consensus target price of $18.00, suggesting a potential upside of 79.64%. Given Zynex's higher possible upside, analysts plainly believe Zynex is more favorable than Vivani Medical.
Zynex has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
In the previous week, Vivani Medical had 3 more articles in the media than Zynex. MarketBeat recorded 4 mentions for Vivani Medical and 1 mentions for Zynex. Zynex's average media sentiment score of 1.30 beat Vivani Medical's score of 0.87 indicating that Zynex is being referred to more favorably in the news media.
Zynex has a net margin of 4.33% compared to Vivani Medical's net margin of 0.00%. Zynex's return on equity of 16.34% beat Vivani Medical's return on equity.
Zynex received 21 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 51.16% of users gave Zynex an outperform vote.
Vivani Medical has a beta of 3.26, indicating that its stock price is 226% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500.
6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 55.6% of Vivani Medical shares are held by insiders. Comparatively, 52.1% of Zynex shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Zynex beats Vivani Medical on 12 of the 16 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
